344 related articles for article (PubMed ID: 21673535)
21. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
[TBL] [Abstract][Full Text] [Related]
22. The molecular genetics of pancreatic ductal carcinoma.
Sohn TA
Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
[TBL] [Abstract][Full Text] [Related]
23. Current status of gene expression profiling of pancreatic cancer.
Goonetilleke KS; Siriwardena AK
Int J Surg; 2008 Feb; 6(1):81-3. PubMed ID: 18359465
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sato N; Fukushima N; Matsubayashi H; Iacobuzio-Donahue CA; Yeo CJ; Goggins M
Cancer; 2006 Jul; 107(2):251-7. PubMed ID: 16752411
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes.
Chifenti B; Morelli M; Zavaglia M; Coviello DA; Guerneri S; Santucci A; Paffetti A; Masetti M; Locci MT; Bertacca G; Capodanno A; Collecchi P; Campani D; Mosca F; Bevilacqua G; Cavazzana AO
Pancreas; 2009 Mar; 38(2):184-96. PubMed ID: 19002021
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
28. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
Izeradjene K; Combs C; Best M; Gopinathan A; Wagner A; Grady WM; Deng CX; Hruban RH; Adsay NV; Tuveson DA; Hingorani SR
Cancer Cell; 2007 Mar; 11(3):229-43. PubMed ID: 17349581
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
Furukawa T
J Hepatobiliary Pancreat Surg; 2007; 14(3):233-7. PubMed ID: 17520197
[TBL] [Abstract][Full Text] [Related]
30. Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell.
Li Y; Qian H; Li X; Wang H; Yu J; Liu Y; Zhang X; Liang X; Fu M; Zhan Q; Lin C
J Gene Med; 2009 Jan; 11(1):3-13. PubMed ID: 19003803
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of pancreatic cancer--new aspects and targets.
Schneider G; Hamacher R; Eser S; Friess H; Schmid RM; Saur D
Anticancer Res; 2008; 28(3A):1541-50. PubMed ID: 18630509
[TBL] [Abstract][Full Text] [Related]
32. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
Mazur PK; Siveke JT
Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M
Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642
[TBL] [Abstract][Full Text] [Related]
34. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
35. [Biological aspects of pancreatic cancer].
Tonel E; Carbone A; Scirelli T; Bellone G; Emanuelli G
Minerva Med; 2005 Apr; 96(2):87-94. PubMed ID: 16172578
[TBL] [Abstract][Full Text] [Related]
36. [Recent advances in diagnosis of pancreatic cancer].
Yamaguchi K; Ogawa Y; Yokohata K; Konomi H; Nakamura M; Nagata S; Tanaka M
Gan To Kagaku Ryoho; 2005 May; 32(5):612-6. PubMed ID: 15918559
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
38. A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma.
Papaconstantinou IG; Lykoudis PM; Gazouli M; Manta A; Polymeneas G; Voros D
Pancreas; 2012 Jul; 41(5):671-7. PubMed ID: 22695087
[TBL] [Abstract][Full Text] [Related]
39. Lessons learned from a complete remission of advanced metastatic pancreatic ductal adenocarcinoma.
Mathew BM; Daas AY; Centeno BA; Hoffe S; Valone T; Patel M; Springett GM
Clin Adv Hematol Oncol; 2012 May; 10(5):340-3. PubMed ID: 22706548
[No Abstract] [Full Text] [Related]
40. Prognostic signature for pancreatic cancer: are we close?
Yeh JJ
Future Oncol; 2009 Apr; 5(3):313-21. PubMed ID: 19374539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
